US Stock MarketDetailed Quotes

AMLX Amylyx Pharmaceuticals

Watchlist

5.745
+0.475+9.01%

Trading Nov 25 14:12 ET

393.81MMarket Cap-1503P/E (TTM)

Amylyx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-704.22%-41.57M

-873.38%-66.58M

90.36%-489K

106.63%11.92M

127.27%13.55M

88.00%-5.17M

118.53%8.61M

87.52%-5.07M

-140.47%-179.87M

-75.96%-49.7M

Net income from continuing operations

-447.98%-72.7M

-429.35%-72.7M

-7,652.00%-118.79M

124.84%49.27M

111.08%4.73M

138.87%20.89M

140.83%22.07M

103.29%1.57M

-125.60%-198.38M

-50.66%-42.7M

Depreciation and amortization

-26.82%221K

-25.98%208K

54.41%315K

123.41%1.09M

65.38%301K

83.03%302K

167.62%281K

482.86%204K

836.54%487K

727.27%182K

Other non cash items

--36.2M

--805K

--22K

----

Change In working capital

68.89%-10.6M

59.95%-8.7M

101.43%164K

-3,901.28%-65.66M

113.65%1.56M

-770.70%-34.06M

-1,241.59%-21.71M

-511.02%-11.45M

-135.71%-1.64M

-926.64%-11.41M

-Change in receivables

-53.71%2.24M

200.22%16.56M

1,092.74%19.82M

-66.82%-24.72M

24.46%-11.04M

2,719.46%4.85M

-137,625.00%-16.53M

-199,500.00%-2M

-10,190.97%-14.82M

-10,053.47%-14.62M

-Change in inventory

--0

30.44%-9.25M

-648.58%-73.13M

-187.65%-26.48M

-2,388.81%-14.01M

---19.33M

---13.3M

---9.77M

---9.21M

-Change in prepaid assets

161.15%3.84M

140.47%3.76M

27.00%-2.1M

7.74%-4.82M

218.66%2.78M

-634.75%-6.28M

86.86%1.56M

41.06%-2.88M

-16.38%-5.22M

13.96%-2.34M

-Change in payables and accrued expense

10.48%-16.6M

-329.20%-28.96M

-224.14%-8.43M

34.30%37.48M

146.96%36.59M

-507.45%-18.54M

1,524.29%12.64M

-12.52%6.79M

206.66%27.91M

744.27%14.82M

-Change in other current assets

10.81%492K

11.69%497K

55.28%677K

32.99%1.57M

-43.09%243K

6.22%444K

6.97%445K

631.71%436K

843.20%1.18M

--427K

-Change in other current liabilities

-10.60%-574K

-10.82%-553K

-10.59%-543K

-122.57%-2.04M

-10.60%-532K

-64.24%-519K

-326.50%-499K

-16,266.67%-491K

---917K

---481K

Cash from discontinued investing activities

Operating cash flow

-704.22%-41.57M

-873.38%-66.58M

90.36%-489K

106.63%11.92M

127.27%13.55M

88.00%-5.17M

118.53%8.61M

87.52%-5.07M

-140.47%-179.87M

-75.96%-49.7M

Investing cash flow

Cash flow from continuing investing activities

135.91%38.82M

-123.50%-28.96M

-98.54%819K

138.52%92.05M

109.17%20.93M

-228.61%-108.09M

2,661.59%123.22M

156.38%55.99M

-414.99%-238.99M

-8,208.74%-228.18M

Net PPE purchase and sale

105.32%19K

67.99%-89K

73.20%-67K

50.87%-1.24M

42.58%-356K

22.22%-357K

74.84%-278K

26.90%-250K

-615.58%-2.53M

-233.33%-620K

Net investment purchase and sale

169.62%75M

-123.38%-28.87M

-98.42%886K

139.45%93.29M

109.35%21.28M

-227.49%-107.73M

2,118.43%123.5M

156.83%56.24M

-413.46%-236.46M

-7,685.33%-227.56M

Cash from discontinued investing activities

Investing cash flow

135.91%38.82M

-123.50%-28.96M

-98.54%819K

138.52%92.05M

109.17%20.93M

-228.61%-108.09M

2,661.59%123.22M

156.38%55.99M

-414.99%-238.99M

-8,208.74%-228.18M

Financing cash flow

Cash flow from continuing financing activities

-91.00%80K

-98.05%27K

-87.40%131K

-99.18%3.54M

-99.90%230K

889K

267.15%1.38M

-99.48%1.04M

172.41%431.79M

21,899.25%232.16M

Net issuance payments of debt

----

--0

----

--0

----

Net common stock issuance

----

--0

----

--432.45M

--231.55M

Net preferred stock issuance

----

--0

----

--0

----

Proceeds from stock option exercised by employees

-50.10%491K

-97.79%47K

-59.14%1.45M

219.51%6.99M

-82.12%347K

--984K

756.45%2.12M

--3.54M

538.19%2.19M

1,238.62%1.94M

Net other financing activities

-332.63%-411K

97.30%-20K

47.38%-1.32M

-21.22%-3.45M

91.20%-117K

---95K

31.23%-740K

-465.38%-2.5M

-4.17%-2.85M

-14.97%-1.33M

Cash from discontinued financing activities

Financing cash flow

-91.00%80K

-98.05%27K

-87.40%131K

-99.18%3.54M

-99.90%230K

--889K

267.15%1.38M

-99.48%1.04M

172.41%431.79M

21,899.25%232.16M

Net cash flow

Beginning cash position

-69.53%75.72M

48.57%171.27M

170.25%170.92M

25.54%63.25M

25.38%135.98M

266.17%248.48M

4.02%115.28M

25.54%63.25M

285.58%50.38M

41.09%108.45M

Current changes in cash

97.62%-2.67M

-171.70%-95.51M

-99.11%461K

731.52%107.52M

175.92%34.71M

-374.32%-112.37M

411.05%133.22M

-14.13%51.96M

-65.34%12.93M

-72.54%-45.72M

Effect of exchange rate changes

276.12%236K

-116.67%-39K

-246.67%-110K

346.15%160K

-53.25%237K

63.69%-134K

86.67%-18K

210.29%75K

-600.00%-65K

5,533.33%507K

End cash Position

-46.11%73.28M

-69.53%75.72M

48.57%171.27M

170.25%170.92M

25.38%135.98M

266.17%248.48M

4.02%115.28M

25.54%63.25M

Free cash flow

-651.92%-41.55M

-900.25%-66.67M

89.55%-556K

105.85%10.68M

126.22%13.2M

87.31%-5.53M

117.51%8.33M

87.01%-5.32M

-142.70%-182.4M

-76.99%-50.32M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-704.22%-41.57M	-873.38%-66.58M	90.36%-489K	106.63%11.92M	127.27%13.55M	88.00%-5.17M	118.53%8.61M	87.52%-5.07M	-140.47%-179.87M	-75.96%-49.7M
Net income from continuing operations	-447.98%-72.7M	-429.35%-72.7M	-7,652.00%-118.79M	124.84%49.27M	111.08%4.73M	138.87%20.89M	140.83%22.07M	103.29%1.57M	-125.60%-198.38M	-50.66%-42.7M
Depreciation and amortization	-26.82%221K	-25.98%208K	54.41%315K	123.41%1.09M	65.38%301K	83.03%302K	167.62%281K	482.86%204K	836.54%487K	727.27%182K
Other non cash items	--36.2M	--805K	--22K	----	----	----	----	----	----	----
Change In working capital	68.89%-10.6M	59.95%-8.7M	101.43%164K	-3,901.28%-65.66M	113.65%1.56M	-770.70%-34.06M	-1,241.59%-21.71M	-511.02%-11.45M	-135.71%-1.64M	-926.64%-11.41M
-Change in receivables	-53.71%2.24M	200.22%16.56M	1,092.74%19.82M	-66.82%-24.72M	24.46%-11.04M	2,719.46%4.85M	-137,625.00%-16.53M	-199,500.00%-2M	-10,190.97%-14.82M	-10,053.47%-14.62M
-Change in inventory	--0	--0	30.44%-9.25M	-648.58%-73.13M	-187.65%-26.48M	-2,388.81%-14.01M	---19.33M	---13.3M	---9.77M	---9.21M
-Change in prepaid assets	161.15%3.84M	140.47%3.76M	27.00%-2.1M	7.74%-4.82M	218.66%2.78M	-634.75%-6.28M	86.86%1.56M	41.06%-2.88M	-16.38%-5.22M	13.96%-2.34M
-Change in payables and accrued expense	10.48%-16.6M	-329.20%-28.96M	-224.14%-8.43M	34.30%37.48M	146.96%36.59M	-507.45%-18.54M	1,524.29%12.64M	-12.52%6.79M	206.66%27.91M	744.27%14.82M
-Change in other current assets	10.81%492K	11.69%497K	55.28%677K	32.99%1.57M	-43.09%243K	6.22%444K	6.97%445K	631.71%436K	843.20%1.18M	--427K
-Change in other current liabilities	-10.60%-574K	-10.82%-553K	-10.59%-543K	-122.57%-2.04M	-10.60%-532K	-64.24%-519K	-326.50%-499K	-16,266.67%-491K	---917K	---481K
Cash from discontinued investing activities
Operating cash flow	-704.22%-41.57M	-873.38%-66.58M	90.36%-489K	106.63%11.92M	127.27%13.55M	88.00%-5.17M	118.53%8.61M	87.52%-5.07M	-140.47%-179.87M	-75.96%-49.7M
Investing cash flow
Cash flow from continuing investing activities	135.91%38.82M	-123.50%-28.96M	-98.54%819K	138.52%92.05M	109.17%20.93M	-228.61%-108.09M	2,661.59%123.22M	156.38%55.99M	-414.99%-238.99M	-8,208.74%-228.18M
Net PPE purchase and sale	105.32%19K	67.99%-89K	73.20%-67K	50.87%-1.24M	42.58%-356K	22.22%-357K	74.84%-278K	26.90%-250K	-615.58%-2.53M	-233.33%-620K
Net investment purchase and sale	169.62%75M	-123.38%-28.87M	-98.42%886K	139.45%93.29M	109.35%21.28M	-227.49%-107.73M	2,118.43%123.5M	156.83%56.24M	-413.46%-236.46M	-7,685.33%-227.56M
Cash from discontinued investing activities
Investing cash flow	135.91%38.82M	-123.50%-28.96M	-98.54%819K	138.52%92.05M	109.17%20.93M	-228.61%-108.09M	2,661.59%123.22M	156.38%55.99M	-414.99%-238.99M	-8,208.74%-228.18M
Financing cash flow
Cash flow from continuing financing activities	-91.00%80K	-98.05%27K	-87.40%131K	-99.18%3.54M	-99.90%230K	889K	267.15%1.38M	-99.48%1.04M	172.41%431.79M	21,899.25%232.16M
Net issuance payments of debt	----	----	----	--0	----	----	----	----	--0	----
Net common stock issuance	----	----	----	--0	----	----	----	----	--432.45M	--231.55M
Net preferred stock issuance	----	----	----	--0	----	----	----	----	--0	----
Proceeds from stock option exercised by employees	-50.10%491K	-97.79%47K	-59.14%1.45M	219.51%6.99M	-82.12%347K	--984K	756.45%2.12M	--3.54M	538.19%2.19M	1,238.62%1.94M
Net other financing activities	-332.63%-411K	97.30%-20K	47.38%-1.32M	-21.22%-3.45M	91.20%-117K	---95K	31.23%-740K	-465.38%-2.5M	-4.17%-2.85M	-14.97%-1.33M
Cash from discontinued financing activities
Financing cash flow	-91.00%80K	-98.05%27K	-87.40%131K	-99.18%3.54M	-99.90%230K	--889K	267.15%1.38M	-99.48%1.04M	172.41%431.79M	21,899.25%232.16M
Net cash flow
Beginning cash position	-69.53%75.72M	48.57%171.27M	170.25%170.92M	25.54%63.25M	25.38%135.98M	266.17%248.48M	4.02%115.28M	25.54%63.25M	285.58%50.38M	41.09%108.45M
Current changes in cash	97.62%-2.67M	-171.70%-95.51M	-99.11%461K	731.52%107.52M	175.92%34.71M	-374.32%-112.37M	411.05%133.22M	-14.13%51.96M	-65.34%12.93M	-72.54%-45.72M
Effect of exchange rate changes	276.12%236K	-116.67%-39K	-246.67%-110K	346.15%160K	-53.25%237K	63.69%-134K	86.67%-18K	210.29%75K	-600.00%-65K	5,533.33%507K
End cash Position	-46.11%73.28M	-69.53%75.72M	48.57%171.27M	170.25%170.92M	170.25%170.92M	25.38%135.98M	266.17%248.48M	4.02%115.28M	25.54%63.25M	25.54%63.25M
Free cash flow	-651.92%-41.55M	-900.25%-66.67M	89.55%-556K	105.85%10.68M	126.22%13.2M	87.31%-5.53M	117.51%8.33M	87.01%-5.32M	-142.70%-182.4M	-76.99%-50.32M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data